Teva accuses Lilly in U.S. court of infringing migraine drug patents

BOSTON (Reuters) - Teva Pharmaceutical Industries Ltd has filed a patent infringement lawsuit seeking to block Eli Lilly and Co from bringing its migraine drug galcanezumab to market in the United States.